Vanguard Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$131M Buy
11,279,195
+135,767
+1% +$1.58M ﹤0.01% 1712
2025
Q1
$82.8M Buy
11,143,428
+428,540
+4% +$3.18M ﹤0.01% 1874
2024
Q4
$64.2M Buy
10,714,888
+75,448
+0.7% +$452K ﹤0.01% 2059
2024
Q3
$54.5M Buy
10,639,440
+412,529
+4% +$2.11M ﹤0.01% 2137
2024
Q2
$37M Sell
10,226,911
-2,642,907
-21% -$9.57M ﹤0.01% 2265
2024
Q1
$41.3M Buy
12,869,818
+102,134
+0.8% +$328K ﹤0.01% 2249
2023
Q4
$62.6M Buy
12,767,684
+518,642
+4% +$2.54M ﹤0.01% 2099
2023
Q3
$66.8M Buy
12,249,042
+196,555
+2% +$1.07M ﹤0.01% 2001
2023
Q2
$80.9M Buy
12,052,487
+75,073
+0.6% +$504K ﹤0.01% 1964
2023
Q1
$106M Buy
11,977,414
+183,246
+2% +$1.62M ﹤0.01% 1804
2022
Q4
$90.1M Buy
11,794,168
+122,385
+1% +$935K ﹤0.01% 1860
2022
Q3
$83.1M Buy
11,671,783
+95,409
+0.8% +$679K ﹤0.01% 1909
2022
Q2
$93.7M Buy
11,576,374
+485,540
+4% +$3.93M ﹤0.01% 1864
2022
Q1
$154M Buy
11,090,834
+59,546
+0.5% +$827K ﹤0.01% 1715
2021
Q4
$310M Buy
11,031,288
+40,615
+0.4% +$1.14M 0.01% 1331
2021
Q3
$374M Buy
10,990,673
+813,014
+8% +$27.6M 0.01% 1168
2021
Q2
$416M Buy
10,177,659
+155,670
+2% +$6.36M 0.01% 1109
2021
Q1
$403M Buy
10,021,989
+366,564
+4% +$14.8M 0.01% 1087
2020
Q4
$571M Buy
9,655,425
+2,589,318
+37% +$153M 0.02% 810
2020
Q3
$344M Buy
7,066,107
+1,424,673
+25% +$69.3M 0.01% 949
2020
Q2
$273M Buy
5,641,434
+1,169,653
+26% +$56.6M 0.01% 1080
2020
Q1
$124M Buy
4,471,781
+2,890,710
+183% +$80.3M 0.01% 1400
2019
Q4
$47.3M Buy
1,581,071
+84,685
+6% +$2.53M ﹤0.01% 2134
2019
Q3
$46.2M Buy
1,496,386
+1,296,386
+648% +$40.1M ﹤0.01% 2108
2019
Q2
$9.66M Buy
+200,000
New +$9.66M ﹤0.01% 2880